Verizon’s Kyle Malady plans 1,100-share sale

Kyle Malady files a Rule 144 notice to sell 1,100 Verizon (VZ) shares, following three similar sales in the prior three months.

Rhea-AI Filing Summary

VERIZON COMMUNICATIONS INC (VZ) is the issuer of common stock that Kyle Malady plans to sell under Rule 144. The notice covers a proposed sale of 1,100 shares of Verizon common stock through Fidelity Brokerage Services LLC on the NYSE, tied to restricted stock vesting dated March 1, 2026 and described as compensation.

During the prior three months, Kyle Malady reported three Verizon common stock sales of 1,100 shares each, on August 18, 2026 for $53,548.00, August 25, 2026 for $55,066.00, and September 1, 2026 for $55,550.00. The Form 144 is signed by Margaret Campbell as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Kyle Malady.

Key Figures

Planned shares to be sold: 1,100 shares Prior sale on August 18, 2026: 1,100 shares for $53,548.00 Prior sale on August 25, 2026: 1,100 shares for $55,066.00 +2 more

5 metrics

Planned shares to be sold 1,100 shares Proposed sale of Verizon common stock under Rule 144

Prior sale on August 18, 2026 1,100 shares for $53,548.00 Verizon common stock sale reported in past 3 months

Prior sale on August 25, 2026 1,100 shares for $55,066.00 Verizon common stock sale reported in past 3 months

Prior sale on September 1, 2026 1,100 shares for $55,550.00 Verizon common stock sale reported in past 3 months

Restricted stock vesting date March 1, 2026 Origin of the 1,100 shares to be sold as compensation

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 03/01/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Kyle Malady"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing disclose for VERIZON COMMUNICATIONS INC (VZ)?

It discloses that Kyle Malady intends to sell 1,100 shares of Verizon common stock under Rule 144, through Fidelity Brokerage Services LLC on the NYSE, with the shares originating from restricted stock vesting on March 1, 2026 as compensation.

How many VZ shares is Kyle Malady currently planning to sell under this Form 144?

The notice covers a proposed sale of 1,100 shares of Verizon Communications Inc common stock. These shares are to be sold through Fidelity Brokerage Services LLC on the NYSE and are linked to restricted stock vesting dated March 1, 2026.

What prior VZ stock sales by Kyle Malady are reported in the past three months?

The filing lists three prior Verizon common stock sales by Kyle Malady: 1,100 shares on August 18, 2026 for $53,548.00, 1,100 shares on August 25, 2026 for $55,066.00, and 1,100 shares on September 1, 2026 for $55,550.00.

What is the origin of the VZ shares to be sold under this Form 144?

The 1,100 shares of Verizon common stock to be sold are described as arising from restricted stock vesting on March 1, 2026, categorized as compensation and issued by the company as the issuer.

Who is executing the planned Verizon (VZ) share sale on behalf of Kyle Malady?

The planned sale is to be executed through Fidelity Brokerage Services LLC. The Form 144 is signed by Margaret Campbell, as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Kyle Malady.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 09:54 AM Accepted by SEC EDGAR 09/08/2026 - 09:54 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001760581
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERIZON COMMUNICATIONS INC
SEC File Number	001-08606
Address of Issuer	1095 AVENUE OF THE AMERICAS NEW YORK NEW YORK 10036
Phone	212-395-1000
Name of Person for Whose Account the Securities are To Be Sold	Malady Kyle
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1100	54978.00	4154775202	09/08/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2026	Restricted Stock Vesting	Issuer			1100	03/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kyle Malady 1095 Avenue of the Americas New York NY 10036	Common	08/18/2026	1100	53548.00
Kyle Malady 1095 Avenue of the Americas New York NY 10036	Common	08/25/2026	1100	55066.00
Kyle Malady 1095 Avenue of the Americas New York NY 10036	Common	09/01/2026	1100	55550.00

144: Remarks and Signature

Remarks
Date of Notice	09/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Margaret Campbell, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kyle Malady
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)